Background: The leading cause of mortality in the country is heart disease with a rate of 94.5 deaths per 100,000 Filipinos. Multi-vessel coronary artery disease (MV-CAD) patients carry an increased procedural risk especially those with increased lesion complexity or unfavorable anatomy.

Objective: The study aims to determine the variables that will predict procedural success and clinical outcome among MV-CAD patients undergoing percutaneous coronary intervention

Setting: Philippine Heart Center , Quezon Ci ty, Philippines

Methodology: This retrospective cohort study obtained data from the four-year Philippine Heart Center Registry consisting of 1,030 patients who underwent Multi-Vessel Percutaneous Coronary Intervention (MV-PCI) from January 2009 to January 2012 at the Cardiac Catheterization Laboratory.

Results: Significant predictors for improved procedural success and reduced risk for major cardiovascular events was evident in male patients, those with mild diastolic dysfunction (grade I or II) and patients on statin therapy. The variables with unfavorable procedural and clinical outcome are female patients, those with unstable angina, STEMI, heart failure, COPD, the need for IABP counterpulsation and a left main artery coronary lesion.

Conclusion: The results reflect a local “real-life scenario” providing important information on the predictors of outcome among Filipino patients with multi-vessel disease undergoing percutaneous coronary intervention. The information obtained is clinically relevant for both cardiologist and interventionist providing an important risk strat i f icat ion and contributing to the holistic delivery of cardiovascular care.

Keywords: multi-vessel disease, procedural success, coronary artery disease, percutaneous coronary intervention  

1. Murphy SL, Xu J, Kochanek KD, Division of Vital Statistics. National Vital Statistics Reports, Death: Final Data for 2010. U.S. Department of Health and Human Services. Center for Disease Control and Prevention. Volume 61, Number 4, 2013 May. [http://www.cdc.gov/nchs/fastats/ heart.htm]
2. Department of Health (Kagawaran ng Kalusugan). Mortality: Ten (10) Leading Causes, Philippines. Philippine Health Statistics 1982 – 2009. Updated 2013 April. [http:// www.doh.gov.ph/node/198.html]
3. Endo M. The history and evolution of coronary artery bypass grafting. Nihon Geka Gakkai Zasshi. 2000;101(12):827-832.
4. Mueller, R.L., Sanborn, T.A. The history of interventional cardiology: cardiac cathetherization, angioplasty and related interventions. Am Heart J. 1995;129(1):146-172.
5. Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, et.al.; EXECUTIVE Trial Investigators. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease). JACC Cardiovasc Interv. 2013;6(10):1012-1022.
6. Hahalis G, Dangas G, Davlouros P, Alexopoulos D. Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAX. Int J Cardiol. 2011;153(2):126-134.
7. Srinivas VS, Brooks MM, Detre KM, King SB, Jacobs AK, Johnston J, Williams DO. Contemporary percutaneous coronary intervention versus balloon angioplasty for multi-vessel coronary artery disease: A Comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) Study. Circulation. 2002;106:1627–1633.
8. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, et.al. Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease. A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS Trials. Circulation. 2008;118:1146-1154.
9. Casey C, Faxon DP. Multi-Vessel Coronary Disease and Percutaneous Coronary Intervention. Heart. 2004;90:341–346.
10. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features. Circulation. 2004;109:2290-2295.
11. Reynolds HR, Hochman JS. Cardiogenic Shock: Current Concepts and Improving Outcomes. Circulation. 2008;117:686- 697.
12. Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J, et.al., for the IABP-SHOCK II Trial Investigators. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. N Engl J Med. 2012;367:1287-1296.
13. Gutiérrez-Chico JL, Mehilli J. Gender differences in cardiovascular therapy: focus on antithrombotic therapy and percutaneous coronary intervention. Drugs. 2013;73(17):1921- 1933.
14. Zhang B, Jiang DM, Sun YJ, Ren LN, Zhang ZH, Gao Y, et.al. Investigation Collaborative Group. The role of gender difference on the prognosis of ST-segment elevation myocardial infarction (STEMI) in patients treated with primary percutaneous coronary intervention. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33(1):92-98. [Article in Chinese]
15. Lee CY, Hairi NN, Ahmad WA, Ismail O, Liew HB, Zambahari R, et.al., for the NCVD-PCI Investigators. Are There Gender Differences in Coronary Artery Disease? The Malaysian National Cardiovascular Disease Database – Percutaneous Coronary Intervention (NCVDPCI) Registry. PLoS ONE 2013;8(8): e72382.
16. Khashan MY, Pinsky MR. Does intra-aortic balloon support for myocardial infarction with cardiogenic shock improve outcome? Crit Care. 2013;6,17(2):307.
17. Williams MC, Murchison JT, Edwards LD, Agustí A, Bakke P, Calverley PM, et.al.; for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 2014. [http:// thorax.bmj.com/content/early/2014/01/28/thoraxjnl-2012-203151. full]
18. Cavaille`s A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, Meurice J, Morel H, Person-Tacnet C, Leroyer C, Diot P. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–475.
19. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121:2645–2653.
20. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574–e651.
21. Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol. 2008;51:538–545.
22. Park SJ, Kim YH, Park DW, et al. Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2011;364:1718–1727.
23. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193–1202.
24. Mandinov L, Eberli FR, Seiler C, Hess OM. Diastolic heart failure. Cardiovascular Research 2000;45:813–825.
25. McCullough, PA. Interface Between Renal Disease and Cardiovascular Illness. Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine. 9th Edition Saunders 2012. Chapter 93, Page 1934-1948.
26. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799.
27. Szczech LA, Best PJ, Crowley E, et.al. Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation. Circulation 2002;105:2253.